Stay updated on Fulvestrant & Pyrotinib in HR+/HER2+ Clinical Trial
Sign up to get notified when there's something new on the Fulvestrant & Pyrotinib in HR+/HER2+ Clinical Trial page.

Latest updates to the Fulvestrant & Pyrotinib in HR+/HER2+ Clinical Trial page
- ChecktodayChange DetectedA new revision entry v3.6.6 was added to the study record history. The previous revision v3.6.5 was removed from the history.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page now shows Revision: v3.6.5, replacing the previous v3.6.4, signaling a new site release of the ClinicalTrials.gov interface on the study history page.SummaryDifference0.1%

- Check35 days agoChange DetectedThe site software version was updated from v3.6.3 to v3.6.4, indicating an underlying platform or UI update rather than changes to study content.SummaryDifference0.1%

- Check56 days agoChange DetectedThe revision label on the page shows v3.6.3, replacing the previous v3.6.2, indicating a maintenance update to the interface for this study history view.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision label updated from v3.6.0 to v3.6.2 on the history page, signaling a newer software release. This is a non-content change reflecting an update to the page's underlying system.SummaryDifference0.1%

- Check77 days agoChange DetectedThe study history now shows 'Check who can join' and 'Find Contact Information' for easier participation and outreach. The revision label updates from v3.5.5 to v3.6.0.SummaryDifference0.6%

Stay in the know with updates to Fulvestrant & Pyrotinib in HR+/HER2+ Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fulvestrant & Pyrotinib in HR+/HER2+ Clinical Trial page.